EMJ GOLD

The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements

The pandemic revived all areas of vaccine development. Read more about the effect of Covid-19 on investment, development and commercialisation of vaccines.

A world without illness or disease sounds like a far-off fantasy, but some players in the pharmaceutical industry are investigating how to transform this vision into a reality.

As China enters the year of the tiger – a symbol of strength and bravery – GOLD journeys to this powerhouse nation to explore how it has become the second largest pharmaceutical market in the world

Recruitment for pharma is not an easy task, especially when the goal is to appeal to the younger generation. Read the article and find out more.

The pharmaceutical industry is on a journey to create more diverse and inclusive working cultures. Read the article to find out more.

How can pharma companies improve inclusivity across their R&D cycles?

Biotechs have stood as agile hubs for drug discovery, but now they are being coveted by investors.